Suven Life Sci Standalone September 2020 Net Sales at Rs 8.98 crore, up 547.27% Y-o-Y
October 29, 2020 / 10:14 AM IST
Reported Standalone quarterly numbers for Suven Life Sciences are:Net Sales at Rs 8.98 crore in September 2020 up 547.27% from Rs. 1.39 crore in September 2019.
Quarterly Net Loss at Rs. 1.90 crore in September 2020 up 83.09% from Rs. 11.23 crore in September 2019.
EBITDA stands negative at Rs. 1.57 crore in September 2020 up 84.49% from Rs. 10.12 crore in September 2019.
Suven Life Sci shares closed at 48.00 on October 28, 2020 (NSE) and has given 14.97% returns over the last 6 months and -84.00% over the last 12 months.
| Suven Life Sciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'20 | Jun'20 | Sep'19 | | Net Sales/Income from operations | 8.98 | 1.43 | 1.39 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 8.98 | 1.43 | 1.39 | | EXPENDITURE | | Consumption of Raw Materials | -- | -- | -- | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 4.86 | 3.41 | 4.20 | | Depreciation | 1.07 | 1.06 | 1.42 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | 7.02 | 4.95 | 7.51 | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.94 | 0.86 | 2.18 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.92 | -8.85 | -13.92 | | Other Income | 2.28 | 2.53 | 2.38 | | P/L Before Int., Excpt. Items & Tax | -2.64 | -6.33 | -11.54 | | Interest | 0.25 | 0.22 | 0.10 | | P/L Before Exceptional Items & Tax | -2.89 | -6.54 | -11.64 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -2.89 | -6.54 | -11.64 | | Tax | -0.99 | -2.47 | -0.41 | | P/L After Tax from Ordinary Activities | -1.90 | -4.08 | -11.23 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -1.90 | -4.08 | -11.23 | | Equity Share Capital | 12.73 | 12.73 | 12.73 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.15 | -0.32 | -0.88 | | Diluted EPS | -0.15 | -0.32 | -0.88 | | EPS After Extra Ordinary | | Basic EPS | -0.15 | -0.32 | -0.88 | | Diluted EPS | -0.15 | -0.32 | -0.88 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
IPL 2021 DC vs MI | Player of the match: Amit Mishra Watch more 
Is it safe to get vaccinated when you have COVID-19 symptoms? Doctors explain Watch more 
Centre not in favour of a 2020-kind of pan-India lockdown, says FM Nirmala Sitharaman Watch more 
Why are vaccinated people testing positive for COVID-19? Watch more 
